Palmer Square Capital BDC Reports Significant Decline in NAV and EPS, Increased Losses in Q1 2026
PSBD sits 19% above its 52-week low of $9.34 on elevated volume (2.1× avg).
Summary
Palmer Square Capital BDC Inc. reported a significant decline in NAV per share and a substantial increase in net losses and negative EPS for Q1 2026, signaling worsening financial performance.
Key Events · Earnings and Guidance · PSBD
-
NAV Per Share Declined Significantly
Net Asset Value per common share decreased to $13.30 as of March 31, 2026, down from $14.85 at December 31, 2025, representing a decline of over 10% in one quarter.
-
Net Losses from Operations Widened Substantially
The net decrease in net assets resulting from operations was $(37.2) million for the three months ended March 31, 2026, a significant increase from $(8.4) million in the prior year period.
-
EPS Deteriorated
Basic and diluted net increase (decrease) in net assets resulting from operations per common share was $(1.19) for Q1 2026, compared to $(0.26) for Q1 2025.
-
Increased Realized and Unrealized Losses
The company reported net realized losses of $(10.7) million and net unrealized losses of $(37.6) million for the quarter, both significantly higher than the prior year.
Analysis · PSBD · Unknown
Palmer Square Capital BDC Inc. reported a substantial deterioration in its financial performance for the first quarter of 2026, continuing a negative trend from the prior fiscal year. Net Asset Value (NAV) per share declined by over 10% quarter-over-quarter, and net losses from operations widened significantly. This indicates ongoing challenges in its investment portfolio, reflected in increased realized and unrealized losses. While the company and its advisor are actively repurchasing shares, and the asset coverage ratio remains above regulatory minimums, the magnitude of the financial decline is a critical concern for investors.
At the time of this filing, PSBD was trading at $11.15 on NYSE in the Unknown sector, with a market capitalization of approximately $347.9M. The 52-week trading range was $9.34 to $14.98. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.